SYMPOSIUM: KERATOCONUS |
|
Year : 2013 | Volume
: 61
| Issue : 8 | Page : 428-429 |
|
Current status of accelerated corneal cross-linking
Michael Mrochen
IROC Innocross AG, Technoparkstrasse 1, Zurich, Switzerland
Correspondence Address:
Michael Mrochen PhD, IROC Innocross AG, Zurich, Switzerland
Source of Support: None, Conflict of Interest: Shareholder of IROC
Innocross AG. | Check |
DOI: 10.4103/0301-4738.116075
|
|
Corneal cross-linking with riboflavin is a technique to stabilize or reduce corneal ectasia, in diseases such as keratoconus and post-laser-assisted in situ keratomileusis (LASIK) ectasia. There is an interest by patient as well as clinicians to reduce the overall treatment time. Especially, the introduction of corneal cross-linking in combination with corneal laser surgery demands a shorter treatment time to assure a sufficient patient flow. The principles and techniques of accelerated corneal cross-linking is discussed. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|